Jennifer Boggs

ConjuChem Raises C$21.7M For Upcoming DAC Studies

Feb. 15, 2005

By Jennifer Boggs

ConjuChem Raises C$21.7M For Upcoming DAC Studies

Feb. 15, 2005

By Jennifer Boggs

Accentia Files For $86M IPO To Fund Trials, Pay Off Debt

Feb. 15, 2005

By Jennifer Boggs

Amgen Confirms GDNF Halt In Parkinson's Development

Feb. 14, 2005

By Jennifer Boggs

Amgen Inc. will return to the drawing board with its drug for Parkinson's disease, GDNF, after further review of preclinical studies showed a risk of brain damage. (BioWorld Today)

Amgen Confirms GDNF Halt In Parkinson's Development

Feb. 14, 2005

By Jennifer Boggs

Amgen Inc. will return to the drawing board with its drug for Parkinson's disease, GDNF, after further review of preclinical studies showed a risk of brain damage. (BioWorld Today)